Abstract Library

#3882 Adjuvant therapy for pancreatic neuroendocrine tumors – Expert consensus and recommendations for future research

Introduction: With the increase of incidentally diagnosed pancreatic neuroendocrine tumors (panNEN), more patients are treated with curative intent. Survival in patients with a panNEN is impacted by the development of recurrence, but postoperative adjuvant therapy is not yet recommended in guidelines due to absence of evidence. Multiple clinicopathological characteristics have been described in literature to identify patients at high-risk of recurrence who might benefit from adjuvant treatment. Since panNEN are rare tumors, prospective randomized controlled studies on the role of adjuvant therapy in these patients have not been performed.

Conference:

Presenting Author: Heidsma C

Authors: Heidsma C, Engelsman A, Klümpen H, Falconi M, Frilling A,

Keywords: pancreatic neuroendocrine tumor, recurrence, adjuvant therapy, prevention, expert consensus, future research,

#3101 Value of laparoscopy for resection of small bowel neuroendocrine neoplasms including central mesenteric lymphadenectomy

Introduction: Literature on laparoscopic resection of small bowel neuroendocrine neoplasms consists of single case descriptions or small selected case-series only, likely because of challenging mesenteric lymphadenectomy.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Kaçmaz E, van Eeden S, Koppes J, Klümpen H, Bemelman W,

Keywords: small bowel, neuroendocrine neoplasm, colorectal surgery, lymphadenectomy, laparoscopy,

#3100 Update on incidence, prevalence, treatment and survival of patients with small bowel neuroendocrine neoplasms in The Netherlands

Introduction: Small bowel neuroendocrine neoplasms (SB-NEN) are a rare cancer with relatively high survival rates compared to other cancers. Population-based studies are ideal to study rare indolent disease.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Kaçmaz E, Farina Sarasqueta A, van Eeden S, Dreijerink K, Klümpen H,

Keywords: epidemiology, survival, treatment, small bowel, neuroendocrine neoplasm, population-based,

#3099 Evaluating nationwide application of minimally invasive surgery for small bowel neuroendocrine neoplasms and the impact on survival

Introduction: Open surgery for small bowel neuroendocrine neoplasms (SB-NEN) is still considered standard-of-care, mainly because of frequently encountered multifocality and central mesenteric masses.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Kaçmaz E, Klümpen H, Bemelman W, Nieveen van Dijkum E, Engelsman A,

Keywords: survival, laparoscopy, surgery, small intestine, neuroendocrine neoplasm,

#2273 The Clinical Value of Circulating Transcript Analysis (NETest) during Follow-Up of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors

Introduction: Follow-up after resection of pancreatic neuroendocrine tumors (pNET) is designed to detect recurrence early, as incidence is reported up to 48%.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Genc C, Jilesen A, Nieveen van Dijkum E, Klümpen H, Van Eijck C,

Keywords: neuroendocrine, pancreas, recurrence, biomarker, NETest, postoperative follow-up,